✦ LIBER ✦

P.4.a.010 Evaluation of the pharmacokinetics and clinical tolerability of the novel anxiolytic BNC210 in healthy volunteers

✍ Scribed by G. Kremmidiotis; S. O'Connor; E. Doolin; P. Rolan

Book ID: 118597447
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 43 KB
Volume: 20
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(10)70787-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.4.a.005 Pharmacodynamic effects of sin

P.4.a.005 Pharmacodynamic effects of single oral doses of the novel anxiolytic compound BNC210 in healthy male volunteers

✍ G. Kremmidiotis; E. Doolin; D. Metzger; E. Drutinus; P. Danjou; S. O'Connor 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

P.1.d.021 Evaluation of the novel anxiol

P.1.d.021 Evaluation of the novel anxiolytic compound BNC210 in a rodent model of cholecystokinin-induced panic

✍ S. O'Connor; B. Huyard; G. Kremmidiotis; S. Wagner; E. Andriambeloson 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Clinical Safety, Tolerability, Pharmacok

Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

✍ Ogata, Koichiro; Mendell-Harary, Jeanne; Tachibana, Masaya; Masumoto, Hiroshi; O 📂 Article 📅 2010 🏛 Sage Publications 🌐 English ⚖ 344 KB

The tolerability and pharmacokinetics of

The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers

✍ E. SEABER; N. ON; S. PHILLIPS; R. CHURCHUS; J. POSNER; P. ROLAN 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

A review of the pharmacokinetics, tolera

A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers

✍ P. Rosenzweig; M. Canal; A. Patat; L. Bergougnan; I. Zieleniuk; G. Bianchetti 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Amisulpride binds selectively to dopamine D(2) and D(3) receptors in the limbic system. Low doses of amisulpride preferentially block presynaptic D(2)/D(3)-dopamine autoreceptors, thereby enhancing dopaminergic transmission, whereas higher doses block postsynaptic receptors, thus inhibiting dopamine

Assessment of the pharmacokinetics, safe

Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers

✍ Samantha Abel; Elna Van Der Ryst; Maria C. Rosario; Caroline E. Ridgway; Christi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 984 KB